National Pharmaceutical Pricing Authority

Type: Organization
Name: National Pharmaceutical Pricing Authority
First reported Apr 10 2014 - Updated Apr 10 2014 - 1 reports

Pricing and packing of medicines

Sir,National Pharmaceutical Pricing Authority (NPPA) should look into pricing medicines in India where same salt is marketed by different companies in varying prices. Antibiotic ‘Ofloxacin’ has Maximum Retail Price (MRP) for 10 tablets of rupees 314.92, ... [Published Daily Excelsior.com - Apr 10 2014]
First reported Apr 10 2014 - Updated Apr 10 2014 - 1 reports

Drugs firm gets bitter pill

BHUBANESWAR: The drugs control administration (DCA) of Odisha has seized stock of Crocin Advance 500 mg tablets marketed by a leading medicine firm for allegedly inflating maximum retail price (MRP) beyond limits permitted by National Pharmaceutical Pricing ... [Published Times of India - Apr 10 2014]
Entities: Crocin, Paracetamol, Drugs
First reported Apr 10 2014 - Updated Apr 10 2014 - 2 reports

Torrent Pharma at record high, Elder up 12% on CCI order

Shares of Torrent Pharma hit record high at Rs 607.70, up 7 percent intraday on Thursday as Competition Commission of India (CCI) approved its acquisition of Elder Pharma 's formulations business in India and Nepal. The fair trade regulator said Torrent ... [Published Moneycontrol.com - Apr 10 2014]
First reported Apr 09 2014 - Updated Apr 10 2014 - 1 reports

CCI clears Torrent-Elder Pharma Rs 2,000 cr deal

Fair trade regulator CCI has approved Torrent Pharma’s proposed Rs 2,000 crore acquisition of Elder Pharma’s formulations business in India and Nepal, saying that the deal does not raise any competition concerns.The deal will help generic medicines maker ... [Published Hindu Business Line - Apr 09 2014]
First reported Apr 03 2014 - Updated Apr 03 2014 - 2 reports

Medicines to cost more

Drugmakers will be permitted to raise the prices of drugs included under the 2013 drug price control order by 6.32 percent in 2014, Business Standard reported Wednesday. The increase in the prices of essential medicines is based on the 6.32 increase ... [Published FirstWord Pharma - Apr 03 2014]
First reported Apr 01 2014 - Updated Apr 01 2014 - 1 reports

India Drug Price-Capper Reports Recovering $6.7 Million In Overcharges

Article # 28140401005Posted: Apr. 1, 2014 6:00 AM GMTExecutive SummaryIndia's National Pharmaceutical Pricing Authority reported it recovered nearly $6.7 million in overcharges by drug makers in the just-ended fiscal year, nearly triple the amount the ... [Published Health News Daily - Apr 01 2014]
First reported Mar 31 2014 - Updated Mar 31 2014 - 1 reports

NPPA doubles recovery from drug firms in FY14

India's National Pharmaceutical Pricing Authority (NPPA) has recovered Rs 40 crore from drugmakers for overcharging customers during the 2013-2014 fiscal year, compared to about Rs 15 crore in the previous year, Business Standard reported Monday. NPPA ... [Published FirstWord Pharma - Mar 31 2014]
First reported Mar 31 2014 - Updated Mar 31 2014 - 1 reports

Rupee rises to cheers

The downward dollar movement against the rupee in the past few days has come as a boon for students and tourists alike. While travel requests have poured in from people wishing to enjoy the summer vacation at serene locales abroad, students willing to ... [Published Calcutta Telegraph - Mar 31 2014]
First reported Mar 28 2014 - Updated Mar 28 2014 - 1 reports

Opening Bell 28 March | Relief for banks as Basel III norms deferred

A file photo of the BSE building in Mumbai. Photo: HTMumbai: Asian markets are trading mixed. According to Bloomberg equities are swinging between gains and losses in morning trade. While banks are gaining, telecommunication shares are leading the declines. ... [Published Livemint.com - Mar 28 2014]
First reported Mar 25 2014 - Updated Mar 25 2014 - 2 reports

India Taking New Look At Price Caps On Essential Drug After Complaints

Article # 28140325005Posted: Mar. 25, 2014 6:00 AM GMTExecutive SummaryIndia's National Pharmaceutical Pricing Authority has begun requesting from drug makers the costs of making their products considered "essential" to the nation as patients face likely ... [Published Health News Daily - Mar 25 2014]
First reported Mar 24 2014 - Updated Mar 25 2014 - 2 reports

Medicine prices likely to go up as regulator set for revision

Prices may rice on drugs in India as the country's National Pharmaceutical Pricing Authority (NPPA) is seeking data from drugmakers on medicine costs, Business Standard reported Monday. Several companies have complained that the basis of price fixing ... [Published FirstWord Pharma - Mar 24 2014]
First reported Mar 20 2014 - Updated Mar 20 2014 - 1 reports

Consumers may have to pay more for insulin analog

A shortage of Wockhardt's insulin glargine product Glaritus may force Indian patients to switch to more expensive imported alternatives, Business Standard reported Thursday. Sources indicated that Wockhardt was unable to manufacture the therapy for at ... [Published FirstWord Pharma - Mar 20 2014]

Quotes

...will most probably be applicable once the manufacturer supplies the drug to the market again after relabeling, which might take a couple of months. "Action can be taken against the retailer for selling and stocking the drug at the overpriced rate, the official explains, in violation of DPCO rules. Penalty may range from suspension of license to prosecution, " explains an official. Last month, FDA seized stock worth Rs. 12 lakh from the firm's Bhiwandi godown which supplies to the entire state
...80 (15 tablets). "We have sought a clarification from our counterparts in Karnataka how such a discrepancy is being allowed" the drugs controller said
"It is further observed that the prices of the medicines are regulated/monitored by National Pharmaceutical Pricing Authority in accordance with applicable rules and regulations" the Commission added
"The underlining principle of the National Pharmaceutical Policy and DPCO, 2013, is to include those medicines that are under National List of Essential Medicines (NLEM) having specific strengths and dosage. Since Calpol Suspension 120mg which is available in market for more than 30 years is not part of NLEM nor DPCO schedule 2013, it is outside its purview" the spokesperson added

More Content

All (100) | News (100) | Reports (0) | Blogs (0) | Audio/Video (0) | Fact Sheets (0) | Press Releases (0)
sort by: Date | Relevance
Maha FDA inspectors to seize stocks of over pri... [Published PharmaBiz - Apr 14 2014]
Pricing and packing of medicines [Published Daily Excelsior.com - Apr 10 2014]
Drugs firm gets bitter pill [Published Times of India - Apr 10 2014]
Torrent Pharma at record high, Elder up 12% on ... [Published Moneycontrol.com - Apr 10 2014]
CCI clears Torrent acquisition [Published Calcutta Telegraph - Apr 10 2014]
CCI clears Torrent-Elder Pharma Rs 2,000 cr deal [Published Hindu Business Line - Apr 09 2014]
State FDA to approach NPPA for overpricing of C... [Published Times of India - Apr 06 2014]
State FDA finds atorvastatin being sold at high... [Published PharmaBiz - Apr 04 2014]
NPPA revises prices of 33 more formulations und... [Published PharmaBiz - Apr 04 2014]
Medicines to cost more [Published FirstWord Pharma - Apr 03 2014]
Medicines to cost more [Published Business Standard India - Apr 03 2014]
"Market-Based" Price Controls in India? [Published Pharmaceutical Executive - Apr 02 2014]
IMS DATA & NEW PRICES [Published PharmaBiz - Apr 02 2014]
India Drug Price-Capper Reports Recovering $6.7... [Published Health News Daily - Apr 01 2014]
NPPA doubles recovery from drug firms in FY14 [Published FirstWord Pharma - Mar 31 2014]
NPPA doubles recovery from drug firms in FY14 [Published Business Standard India - Mar 31 2014]
Rupee rises to cheers [Published Calcutta Telegraph - Mar 31 2014]
No exemption, NPPA to fine drug firm for o... [Published Mumbai Mirror - Mar 29 2014]
After Crocin Advance, Calpol under regulatory lens [Published Business Standard India - Mar 28 2014]
GSK says its Calpol suspension outside DPCO, st... [Published PharmaBiz - Mar 28 2014]
Opening Bell 28 March | Relief for banks as Bas... [Published Livemint.com - Mar 28 2014]
Regulatory pain for GSK's Crocin Advance [Published Business Standard India - Mar 27 2014]
India Taking New Look At Price Caps On Essentia... [Published Health News Daily - Mar 25 2014]
India Taking New Look At Price Caps On Essentia... [Published BioPortfolio - Mar 25 2014]
Maha FDA to approach NPPA for GSK's overpricing... [Published PharmaBiz - Mar 25 2014]
Medicine prices likely to go up as regulator se... [Published FirstWord Pharma - Mar 24 2014]
Medicine prices likely to go up as regulator se... [Published Business Standard India - Mar 24 2014]
Consumers may have to pay more for insulin analog [Published FirstWord Pharma - Mar 20 2014]
Consumers may have to pay more for insulin analog [Published Business Standard India - Mar 20 2014]
FDA stops sale of Crocin products for over... [Published Mumbai Mirror - Mar 18 2014]
1 2 3 4
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.